According to the new research report on "Manufacturing Execution System in Life Sciences Market Forecast to 2033 – Global Analysis – by Offering, Deployment, Organization Size, and Application" published by The Insight Partners, the market value is expected to reach US$ 10,456.54 million by 2033, registering a CAGR of 12.0% from 2023 to 2033.
In terms of revenue, Europe held the second largest manufacturing execution system in life sciences market share for the year 2022. Europe includes well-established economies such as France, Germany, Russia, the UK, and Italy. The region houses a few of the major medical device manufacturers, and the medical device industry in the region has exhibited several cases of MES deployment in the past few years. As medical device companies are embracing digitalization in areas ranging from factory floor automation to back-office administration to enhance efficiency in all departments. There is a growing understanding regarding the need for action to foster the digital transformation of European businesses, including both SMEs and large enterprises. Interreg Europe, co-funded by the European Union, is a European cooperation program that strives to bring together the different regional and local government authorities to develop sustainable and innovative solutions to overcome regional developmental challenges. Their program policy aims to provide an overview of their good practices and measures for fostering the digital transformation of SMEs, focusing on traditional sectors and SMEs with low digital maturity. Many European businesses plan to adopt new digital technologies as part of the digital transformation trend, which is expected to aid the manufacturing execution system in life sciences market growth in the future.
Rising Application in Cell and Gene Therapy Sector Provides Opportunities for Manufacturing Execution System in Life Sciences Market Growth
Cell and gene therapy is one of the growing divisions of the healthcare sector. The growth in the clinical adoption of advanced cell therapy is one of the major factors raising the demand for personalized medicines. In addition, the growing demand for cell therapy, along with the promise it holds, further raises the requirement for MES solutions. It is seen that cell therapy is moving from a manual-oriented lab environment to identifying production scale principles for making the process more robust and error-free, alongside achieving cost optimization. In the cell therapy process, MES can help automate the tracking of the patient’s blood cells through the system, further offering valuable insights into the treatment modality being developed. Furthermore, electronic verification of the process can improve a lab's throughput by negating human errors. In addition, the MES solution can also help reduce risk by alerting operators about problems that could have catastrophic consequences. Several market players are providing MES solutions, particularly for cell and gene manufacturing. For example, POMS Corporation provides POMSnet MES. The MES solution helps regulate industry deliveries such as genealogy, material management, and equipment tracking (instruments, safety hoods, centrifuges, and more). Thus, the growing application and adoption of MES by the market players in cell and gene therapy manufacturing is expected to create an opportunity for the manufacturing execution system in life sciences market growth during the forecast period.
The manufacturing execution system in life sciences market is segmented on the basis of offering, deployment, organization size, and application. Based on the offering, the manufacturing execution system in the life sciences market is segmented into software and services. In terms of revenue, service segment commanded a larger manufacturing execution system in life sciences market share in the year 2022.
Based on deployment, the manufacturing execution system in life sciences market is segmented into on-premise and cloud. In terms of organization size, the manufacturing execution system in life sciences market is segmented into SMEs and large enterprises. Based on application, the manufacturing execution system in life sciences market is segmented into pharmaceutical, biotechnology, and medical devices.
The top five manufacturing execution system in life sciences market players operating in 2022 were Korber AG, Siemens AG, Emerson Electric, Rockwell Automation and Dassault Systemes. The positioning of these “Five Key Players” is derived by giving weightage to the following key performance parameters: overall revenue, segment revenue, geographical reach, customer base, new product launches, market initiatives, investment in technology up-gradation, R&D investments, mergers & acquisitions, and other market-related activities. Various other notable manufacturing execution system in life sciences market players profiled in the global report include General Electric, Apprentice FS Inc, ATS Global, Atachi Systems, LZ Lifescience Ltd, POMS Corporation, and Schneider Electric.
Key Findings of Market Study:
Key stakeholders in the manufacturing execution system (MES) in life sciences market include technology enablers, MES solution providers, regulatory bodies, system integrators/service providers, and the life sciences industry. In recent years, the demand for MES has been increasing due to the large-scale adoption of Pharma 4.0 in the life sciences sector. Technology enablers play a crucial role in the rising adoption of cloud MES solutions. They provide platforms to host MES solutions. The platforms also provide access to various third-party applications, which can help customize an MES solution with ease. Siemens, Korber, and Tulip are among the major MES solution providers. System integrators/service providers are third parties that aid pharmaceutical and medical device manufacturers in developing, customizing, integrating, and maintaining an MES solution in their plants. Several service providers have authorizations from multiple MES solution providers to implement the latter’s solutions in a plant and provide support for the same.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com